Date:
September 10, 2024
Category:
SARS-CoV-2 and influenza A+B antigen test (nasopharyngeal swab)
The SARS-CoV-2 and influenza A+B combination rapid test detects COVID-19 and influenza viruses. COVID-19, caused by SARS-CoV-2, presents with symptoms such as fever, fatigue and coughing, while influenza, caused by influenza A and B viruses, can be mild to severe and can lead to serious complications, especially in high-risk groups such as the elderly and young children. This test allows rapid detection of these respiratory infections.
Contact our sales team for availability and delivery time
What is this test?
The combined rapid test from a single nasopharyngeal swab detects SARS-CoV-2 (COVID-19) and influenza A and B antigens. During seasonal respiratory infections, it helps to quickly differentiate COVID-19 from influenza and aids in decisions regarding antiviral treatment and isolation.
Technical information
- Method
- Lateral flow chromatographic immunoassay
- Result in
- 15 min
- Storage temperature
- 2–30 °C
- Shelf life
- 24 months
- Sensitivity
- 96.4–97.6 %
- Specificity
- 99–99.7 %
- Accuracy
- 98.2–99.1 %
- Equipment
- Not required – visual reading
- Compliance
- CE-marked in vitro diagnostic device
Variants and order codes
| Code | Specimen | Format | Pack size | Accuracy |
|---|---|---|---|---|
| AF-TFEUZ9 | Nasopharyngeal swab | Cassette | 20 tests | 98.2 % |
| AF-9V4AKD | Nasopharyngeal swab | Cassette | 20 tests | 99.1 % |
Accuracy, sensitivity and specificity
| SARS-CoV-2 | Sensitivity: 87.00% | Specificity: 100.00% | |
| Influenza A | Sensitivity: 99.0% | Specificity: 98.9% | Accuracy: 98.9% |
| Influenza B | Sensitivity: 97.7% | Specificity: 99.0% | Accuracy: 98.6% |